Sulfamethox/tmp 400-80mg/5ml Inj
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered as an infusion into a vein over a specified period. Unless your doctor advises you to limit your fluid intake, be sure to drink plenty of non-caffeinated liquids.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
Missing a Dose
If you miss a dose, contact your doctor to receive guidance on the next steps to take.
Lifestyle & Tips
- Maintain good hydration by drinking plenty of fluids, especially during treatment, to help prevent kidney problems.
- Avoid prolonged exposure to sunlight or tanning beds, as this medication can make your skin more sensitive to the sun (photosensitivity). Use sunscreen and wear protective clothing.
- Report any new or worsening symptoms to your healthcare provider immediately.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
High potassium levels: Abnormal heartbeat, confusion, weakness, lightheadedness, dizziness, numbness or tingling, or shortness of breath.
Low blood sugar: Dizziness, headache, sleepiness, weakness, shaking, rapid heartbeat, confusion, hunger, or sweating.
Kidney problems: Inability to urinate, changes in urine output, blood in the urine, or significant weight gain.
Low sodium levels: Headache, difficulty focusing, memory problems, confusion, weakness, seizures, or balance changes.
Lung or breathing problems: Shortness of breath, trouble breathing, cough, or fever.
Pancreas problems (pancreatitis): Severe stomach pain, severe back pain, or severe nausea and vomiting.
Musculoskeletal issues: Muscle or joint pain.
Skin and mucous membrane issues: Purple patches on the skin or mouth.
Neurological issues: Hallucinations (seeing or hearing things that are not there), depression, or mood changes.
Numbness or tingling: Abnormal burning, numbness, or tingling sensations.
Hearing issues: Ringing in the ears.
Swollen glands: Enlarged lymph nodes.
Cardiovascular issues: Chest pain or pale skin.
Severe dizziness or fainting: Sudden loss of balance or consciousness.
Antibiotic-Associated Diarrhea
Diarrhea is a common side effect of antibiotics. However, a severe form called C. diff-associated diarrhea (CDAD) may occur, which can lead to life-threatening bowel problems. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor immediately. Do not treat diarrhea without consulting your doctor first.
Rare but Serious Side Effects
Rarely, severe and potentially life-threatening side effects have occurred with sulfa drugs, including:
Liver problems: Dark urine, fatigue, decreased appetite, nausea, stomach pain, light-colored stools, vomiting, or yellow skin and eyes.
Blood problems: Unusual bruising or bleeding.
Severe skin reactions: Stevens-Johnson syndrome or toxic epidermal necrolysis, characterized by rash, red, swollen, blistered, or peeling skin, red or irritated eyes, mouth, throat, or nose sores, fever, chills, or sore throat.
Other Serious Side Effects
Aseptic meningitis: A severe brain problem that can cause headache, fever, chills, nausea, vomiting, stiff neck, rash, sensitivity to light, sleepiness, or confusion.
Hemophagocytic lymphohistiocytosis (HLH): A life-threatening immune system problem that can cause fever, swollen glands, rash, seizures, confusion, balance changes, or difficulty walking.
Infusion Site Reactions
If the medication leaks from the vein, it may cause irritation around the infusion site. Inform your nurse if you experience redness, burning, pain, swelling, or fluid leakage at the infusion site.
Common Side Effects
Many people experience no side effects or only minor side effects. However, if you notice any of the following symptoms, contact your doctor or seek medical attention if they bother you or persist:
Diarrhea
Stomach pain
Nausea
Vomiting
* Decreased appetite
Reporting Side Effects
If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe skin rash, blistering, peeling skin, or sores in the mouth, nose, eyes, or genitals (signs of Stevens-Johnson syndrome or toxic epidermal necrolysis)
- Yellowing of the skin or eyes (jaundice), dark urine, or pale stools (signs of liver problems)
- Unexplained fever, sore throat, or unusual bruising/bleeding (signs of blood disorders)
- Severe or persistent diarrhea, especially if it contains blood or mucus (may indicate C. difficile infection)
- Signs of kidney problems such as decreased urination, swelling in your feet or ankles
- Muscle weakness, fatigue, or irregular heartbeat (signs of high potassium levels)
Before Using This Medicine
It is essential to inform your doctor about the following conditions to ensure safe treatment:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms.
A diagnosis of anemia caused by a lack of folic acid.
Presence of kidney disease or liver disease.
Any of the following health conditions: asthma, porphyria, thyroid disease, low folate levels, poor absorption, or poor nutrition.
Long-term alcohol consumption or current treatment with seizure medications.
A history of low platelet count when taking trimethoprim or sulfa (sulfonamide) drugs.
Concurrent use of the following medications: amantadine, cyclosporine, dofetilide, indomethacin, leucovorin, methotrexate, or pyrimethamine.
Recent or current use of the following drugs: benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, or trandolapril.
* Use of diuretics (water pills).
Special Considerations for Children:
If your child is under 2 months of age, do not administer this medication. It is not approved for use in infants younger than 2 months.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist to ensure safe treatment. Never start, stop, or modify the dosage of any medication without consulting your doctor.
Precautions & Cautions
Do not exceed the recommended duration of treatment, as this may increase the risk of a second infection. If you have a deficiency of the enzyme G6PD (glucose-6-phosphate dehydrogenase), you may be more susceptible to anemia. This deficiency is more common in individuals of African, South Asian, Middle Eastern, and Mediterranean descent, so it is crucial to discuss this with your doctor.
If you have diabetes (high blood sugar), closely monitor your blood sugar levels while taking this medication. It is also recommended to consult with your doctor before consuming alcohol. Additionally, this medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when exposed to sunlight, and inform your doctor if you experience any unusual sunburn or sensitivity.
In rare cases, this medication can cause a severe and potentially life-threatening reaction, characterized by symptoms such as fever, rash, swollen glands, and problems with organs like the liver, kidney, blood, heart, muscles and joints, or lungs. If you have any concerns or questions, discuss them with your doctor.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Women who are pregnant or become pregnant while taking this medication should contact their doctor immediately, as it may harm the unborn baby. If you are breastfeeding, consult with your doctor to discuss any potential risks to your baby.
Individuals with a sulfite allergy should inform their doctor, as some products may contain sulfites. This medication contains propylene glycol, which can cause serious health problems, including nervous system problems, kidney problems, or other organ problems, if excessive amounts are consumed. If you have any questions or concerns, discuss them with your doctor.
Some products may also contain benzyl alcohol, which can cause serious side effects in newborns and infants. If possible, avoid products containing benzyl alcohol in these age groups, and consult with your doctor to determine if this product contains benzyl alcohol.
Overdose Information
Overdose Symptoms:
- Nausea
- Vomiting
- Diarrhea
- Anorexia
- Headache
- Dizziness
- Crystalluria
- Hematuria
- Anuria
- Megaloblastic anemia (chronic overdose)
- Bone marrow depression (chronic overdose)
- Jaundice (chronic overdose)
What to Do:
Call 1-800-222-1222 (Poison Control). Treatment is supportive and may include gastric lavage, forced diuresis, and alkalinization of urine to increase sulfamethoxazole excretion. Leucovorin may be administered to counteract trimethoprim's effects on folate metabolism. Hemodialysis is moderately effective in removing both components.
Drug Interactions
Contraindicated Interactions
- Dofetilide (increased dofetilide levels, risk of QT prolongation and Torsades de Pointes)
- Methenamine (risk of crystalluria)
Major Interactions
- Warfarin (potentiates anticoagulant effect, increased bleeding risk)
- Methotrexate (increased methotrexate levels, increased risk of myelosuppression)
- Phenytoin (increased phenytoin levels, increased toxicity)
- Digoxin (increased digoxin levels, especially in elderly)
- Cyclosporine (decreased cyclosporine levels, increased nephrotoxicity)
- ACE inhibitors/ARBs/Potassium-sparing diuretics (increased risk of hyperkalemia)
- Spironolactone (increased risk of severe hyperkalemia)
- Thiazide diuretics (increased risk of thrombocytopenia with purpura in elderly)
- Pyrimethamine (increased risk of megaloblastic anemia)
Moderate Interactions
- Oral hypoglycemics (sulfonylureas - increased hypoglycemic effect)
- Rifampin (decreased trimethoprim levels)
- Amantadine (increased amantadine levels, increased toxicity)
- Procainamide (increased procainamide levels)
- Zidovudine (increased zidovudine levels, increased hematologic toxicity)
- Tricyclic antidepressants (increased TCA levels)
Minor Interactions
- Indomethacin (increased sulfamethoxazole levels)
- Diuretics (increased risk of thrombocytopenia in elderly)
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic status and monitor for myelosuppression (e.g., leukopenia, thrombocytopenia, megaloblastic anemia).
Timing: Prior to initiation of therapy.
Rationale: To assess baseline kidney function and guide dosing adjustments, as the drug is primarily renally eliminated.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline hepatic function and monitor for hepatotoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and monitor for hyperkalemia, particularly in patients at risk (e.g., renal impairment, concomitant medications).
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Weekly or bi-weekly, especially during prolonged therapy or in patients at high risk for myelosuppression.
Target: Within normal limits; monitor for significant drops in cell counts.
Action Threshold: Discontinue if significant depression of any formed blood element occurs.
Frequency: Weekly or bi-weekly, especially in patients with renal impairment or on prolonged therapy.
Target: Within patient's baseline or acceptable limits.
Action Threshold: Adjust dose or discontinue if significant decline in renal function.
Frequency: Weekly or bi-weekly, especially in patients with renal impairment, elderly, or on concomitant medications that increase potassium.
Target: 3.5-5.0 mEq/L
Action Threshold: Intervene if potassium >5.5 mEq/L or rapidly rising.
Frequency: Daily, especially during IV administration.
Target: Adequate hydration to prevent crystalluria.
Action Threshold: Ensure adequate hydration; monitor for signs of dehydration or oliguria.
Symptom Monitoring
- Skin rash (especially severe, blistering, or peeling)
- Fever
- Sore throat
- Unusual bleeding or bruising
- Jaundice (yellowing of skin or eyes)
- Dark urine
- Pale stools
- Severe diarrhea (especially if bloody or watery)
- Signs of superinfection (e.g., new or worsening fever, oral thrush, vaginal yeast infection)
- Signs of hyperkalemia (e.g., muscle weakness, fatigue, paresthesias, bradycardia)
Special Patient Groups
Pregnancy
Category D. Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Avoid use during the first trimester due to potential teratogenic effects (folate antagonism) and near term due to risk of kernicterus in the newborn.
Trimester-Specific Risks:
Lactation
Excreted in breast milk. Use with caution. Risk of kernicterus in jaundiced, premature, or G6PD-deficient infants. Generally considered compatible with breastfeeding for healthy, full-term infants after the neonatal period (first 2 months), but monitor for adverse effects.
Pediatric Use
Contraindicated in infants less than 2 months of age due to the risk of kernicterus. Use with caution in children with G6PD deficiency due to risk of hemolytic anemia. Dosage is weight-based for children >2 months.
Geriatric Use
Increased risk of severe adverse reactions, including hyperkalemia, severe skin reactions, bone marrow depression, and renal impairment. Close monitoring of renal function, electrolytes, and CBC is essential. Use lower doses and monitor frequently.
Clinical Information
Clinical Pearls
- Always dilute the injection prior to administration and infuse over 60-90 minutes. Do NOT administer by rapid infusion or bolus injection.
- Ensure adequate hydration to prevent crystalluria and stone formation.
- Monitor for signs of hypersensitivity reactions, including severe skin rashes (SJS/TEN), which can be fatal. Discontinue at the first sign of rash.
- Be vigilant for hyperkalemia, especially in elderly patients, those with renal impairment, or those on concomitant medications that increase potassium.
- This drug can cause false elevations in creatinine levels due to interference with certain laboratory assays, without actual renal dysfunction.
- Consider folate supplementation in patients at risk for folate deficiency (e.g., elderly, malnourished, chronic alcoholics, long-term therapy) to mitigate hematologic side effects.
Alternative Therapies
- For UTIs: Fluoroquinolones (e.g., ciprofloxacin, levofloxacin), Beta-lactams (e.g., amoxicillin/clavulanate, ceftriaxone), Nitrofurantoin, Fosfomycin.
- For PCP: Pentamidine (IV), Atovaquone, Clindamycin + Primaquine.
- For Nocardiosis: Imipenem, Amikacin, Linezolid.